Next Article in Journal
Modeling a Pre-Touch Reaction Distance around Socially Touchable Upper Body Parts of a Robot
Next Article in Special Issue
Factors Affecting the Yield in Formation of Fat-Derived Fragrance Compounds by Yarrowia lipolytica Yeast
Previous Article in Journal
Intersection-Based Routing with Fuzzy Multi-Factor Decision for VANETs
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Applied Sciences
Volume 11
Issue 16
10.3390/app11167302
applsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Molecular Tools to Exploit the Biotechnological Potential of Brettanomyces bruxellensis: A Review

by
Alessandra Di Canito
,
Roberto Foschino
,
Martina Mazzieri
and
Ileana Vigentini
*
Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, Via G. Celoria, 2-20133 Milan, Italy
*
Author to whom correspondence should be addressed.
Appl. Sci. 2021, 11(16), 7302; https://doi.org/10.3390/app11167302
Submission received: 22 June 2021 / Revised: 29 July 2021 / Accepted: 4 August 2021 / Published: 9 August 2021
(This article belongs to the Special Issue Biotechnological Applications of Yeasts in Food Science)
Versions Notes

Abstract

:
The Brettanomyces bruxellensis species plays various roles in both the industrial and food sectors. At the biotechnological level, B. bruxellensis is considered to be a promising species for biofuel production. Its presence in alcoholic beverages can be detrimental or beneficial to the final product; B. bruxellensis can contribute to spoilage of wine and beer, but can also produce good aromas. However, little is known about its genetic characteristics and, despite the complete sequencing of several B. bruxellensis genomes and knowledge of its metabolic pathways, the toolkits for its efficient and easy genetic modification are still underdeveloped. Moreover, the different ploidy states and the high level of genotype diversity within this species makes the development of effective genetic manipulation tools challenging. This review summarizes the available tools for the genetic manipulation of B. bruxellensis and how they may be employed to improve the quality of wine and beer.

1. Introduction

The Brettanomyces genus was first described by Kufferath and Van Laer in 1921, and its primary taxonomic framework was established in 1964 by van der Walt [1]. It is the anamorphic form of the Dekkera genus belonging to the Pichiaceae family [2,3]. The phylogenetic classification of Brettanomyces and Dekkera was first performed in 1987 by Clark–Walker et al., and then in 1993 by Molina et al. [2]. Subsequently, in 2011, Kurtzman et al. reclassified the genus to include five species: D. bruxellensis, D. anomala, B. custersianus, B. nanus, and B. naardenensis [4]. Recently, a new species named B. acidodurans was isolated from olive oil and has been characterized as a strongly acetic–acid–tolerant yeast [5]. In disagreement with the Melbourne Convention (International Code of Nomenclature for algae, fungi, and plants), which states that a single valid name must be assigned under the new code for a fungal species [6], both “Brettanomyces” and “Dekkera” have been used in the scientific literature. However, the designation “Brettanomyces” is more commonly applied in the food and biotechnology industries, wherein the species B. bruxellensis is immediately associated with wine by all the stakeholders of the sector [7,8]. Thus, we preferentially use Brettanomyces in this review, but also use the original names given in the literature cited. B. bruxellensis is the best–known species within the genus; it is a facultative anaerobic yeast that has been isolated from different sources including fruit peels, beer, wine, cheese, kombucha, kefir, tea, olives, sodas, and wooden barrels [9]. This species has a significant role in the production of Belgium–style beer, especially in the aromatic profiles of Lambic and Gueuze beers, via the release during its proliferation of different aromatic compounds such as fusel alcohols and esters (responsible for the floral, fruity, and spicy characteristics) [10,11,12,13,14,15,16]. In contrast, B. bruxellensis is considered to be a spoilage yeast in the wine sector, causing negative sensory properties for products aged in wood [17]. Contamination by this yeast causes the “Brett” character, consisting of unpleasant aromas that are perceived when specific thresholds are exceeded [18]. These compounds include secondary metabolites such as nitrogenous compounds (e.g., 2–acetyl–3,4,5,6–tetrahydropyridine, 2–acetyl–1,2,5,6–tetrahydropyridine, and 2–ethyl–3,4, 5,6–tetrahydropyridine) and/or volatile phenols (4–vinylphenol, 4–vinylguiacol, 4–ethyl phenol, and 4–ethylguiacol), the latter being associated with “horse sweat”, “leather”, “medicinal”, “barnyard”, and other similar descriptors [18,19,20].
Karyotype analyses, intron splice site amplification (ISS–PCR), and microsatellite genetic profiling performed on strains derived from different microbial collections worldwide have revealed that B. bruxellensis strains exhibit a high intraspecific variability, which is also supported by the chromosome number (from four to nine) and the ploidy state [21,22,23]. Karyotype, ploidy, and the source of isolation can be useful in classifying the different strains (e.g., dissimilar B. bruxellensis strains have been obtained from tequila/ethanol, wine, and kombucha environments). Similarly to other yeasts, changes in ploidy are believed to be a driver of adaptation [24]. B. bruxellensis isolated from wine shows specific adaptations, such as tolerance to SO2, which are linked to their diploid or triploid state [23,25]. This aspect deserves a thorough investigation; indeed, while gene duplication in Saccharomyces cerevisiae has been suggested to bring evolutionary and adaptive benefits to the species, recent studies have revealed that non–Saccharomyces yeast species (namely Kluyveromyces marxianus) face environmental stresses via only the up–/downregulation of multiple pathways (anti–osmotic, antioxidative, etc.) rather than a ploidy change [24,26].
B. bruxellensis strains possess all the characteristics (Table 1) required for a great metabolic potential exploitable in biotechnological applications, such as industrial fermentation processes (beer and wines) and biofuel productions (e.g., first– and second–generation ethanol) [27,28,29,30,31,32,33,34,35]. Despite the large amount of information concerning the biotechnological peculiarities of B. bruxellensis in the literature, there have been no reviews focused on the molecular tools that can be used to modify strains for their biotechnological exploitation [27,28,29]. This information may be useful concerning the genetic mechanisms involved in the attractive physiological traits of this species, thus boosting its industrial application prospects. This review aims to provide a wide overview of the currently available tools for the manipulation of B. bruxellensis strains, from conventional to postgenomic era technologies.

2. Development of Molecular Tools for the Genetic Modification of B. bruxellensis

To date, eight different B. bruxellensis strain genomes have been sequenced and deposited in the NCBI (National Center for Biotechnology Information) database (some information can be seen in Table 2). First, the DNA of the wine–isolated B. bruxellensis CBS2499 strain was partially sequenced by Woolfit et al. in 2007 [38]. Later, Piškur et al. (2012) completed its sequencing and discovered that it has the typical characteristics of the hemiascomycetes (gene number, intron size and number, intergenic length, and gene content) [36]. The genome analysis identified 5600 predicted genes, of which several were duplicated, suggesting a diploid form. In the same year, Curtin et al. (2012) fully investigated the genome of another wine–spoilage strain, the widespread triploid AWRI1499 [37], in which a high density of single–nucleotide polymorphisms (SNPs) and an enrichment in genes for membrane proteins and oxidoreductase enzymes were revealed. Thereafter, the genomes of other B. bruxellensis strains were sequenced: (i) CBS2796 (ATCC 52904) strain, isolated from sparkling wine, with a genome length of 11.77 Mb [38]; (ii) UMY321 strain (corresponding to L17) [22] recognized to be diploid, with 82,632 SNPs revealing a high level of heterozygosity [39,40]; (iii) LAMAP2480 strain, with the largest genome found so far (26.99 Mb), has been the subject of study focusing on its spoilage role and biotechnological potential. The genome analysis showed the presence of several genes related to stress tolerance, nutrient uptake, ethanol production, and lignocellulose assimilation [41]; and (iv) UCD 2041 strain isolated from fruit wine, the DNA sequence of which was compared with strains belonging to different Brettanomyces species, such as B. nanus CBS1945, B. anomala CBS8139, B. naardenensis CBS6042, and B. custersianus CBS4805, revealing a large genetic distance within the genus. Moreover, relevant marker genes of domestic adaptation and fermentation were identified in UCD 2041, CBS1945, and CBS8139. Peculiar horizontal gene transfer events, which are probably responsible for the ability of these strains to utilize sucrose, were also detected [42]. Furthermore, CBS11270 is an example of another sequenced strain isolated from industrial ethanol production, with a genome size of 15.39 Mb across four chromosomes and a high level of SNPs (40.6% of which are in coding regions). Genomic analysis showed that this strain is diploid, with several genes replicated in chromosomes 1 and 4, highlighting interchromosomal gene duplications and loss of heterozygosity in some of them [43,44]. Lastly, the CRL–50 strain, which is one of the two oldest known Brettanomyces isolates, was collected from a Carlsberg beer sample in Denmark between the years 1904 and 1908 [44] and sequenced by Colomer et al. [45]. A comparative genome analysis was carried out in order to compare this strain with other B. bruxellensis strains isolated from beer, wine, kombucha, sodas, olives, and bioethanol production plants. The analysis indicated a higher genetic similarity among beer strains than among the wine–spoilage strains, probably resulting from different selection pressures linked with human activities [45]. Despite these recent studies, additional investigations are necessary to explore the great potential of B. bruxellensis strains in terms of bioengineering applications.

2.1. Drug Sensitivity

Drug sensitivity is one of the key factors impacting microbial manipulation and the construction of suitable molecular tools. Until now, the sensitivity of B. bruxellensis strains to antibiotics commonly used in molecular biotechnology approaches has not been deeply investigated. Recently, Di Canito et al. carried out experiments with drugs usually applied for the selection of transformed yeast cells (geneticin (G418), nourseothricin (NTC), hygromicin (Hyg), and canavanine (Can)) on six different B. bruxellensis strains (CBS2499, AWRI1499, UMY306, UMY308, UMY397, and UMY406) using the protocols described in the work of Vigentini et al. (2017) [46,47]. All strains were sensitive to G418, NTC, and Hyg at final concentrations higher than 400 μg mL−1. In contrast, Can inhibited the growth of all strains at all tested concentrations. The results related to the CBS2499 and AWRI1499 strains are reported in Table 3. In 2019, Avramova et al. investigated the correlation between drug resistance and SO2 tolerance in B. bruxellensis, demonstrating G418 and NTC to have significant effects on the growth of recombinant clones carrying the corresponding selectable markers [48]. In particular, the growth of AWRI1626 clones resistant to G418 decreased faster than that of those resistant to NTC when the concentration of SO2 was around 0.6 mg L−1, while the AWRI1499 and AWRI1608 transformants showed similar behavior in the presence of all the tested SO2 concentrations, regardless of the antibiotic resistance [48]. Thus, considering this relevant strain–specific response, the influence of stress factors (such as those usually found in a wine–like environment) on the sensitivity to selectable markers useful for the generation of recombinant strains should be carefully considered in order to ensure reliable experimental results.

2.2. Construction of Molecular Cassettes for B. bruxellensis Manipulation

The current molecular tools for the genetic manipulation of B. bruxellensis face many issues, hindering the immediate implementation of this species in biotechnological applications. As mutagenesis through homologous integration is difficult to perform in many non–Saccharomyces yeasts [48], in 2013, Miklenic et al. first attempted and implemented the insertion of a specific genetic element into B. bruxellensis cells via nonhomologous recombination [49]. The authors transformed the CBS2499 strain with a heterologous DNA fragment of 1.9 kb, containing the kanMX4 sequence encoding for G418 resistance (G418R) and flanked with the regions 5′Sc and 3′Sc (220 bp of the 5′ end and 165 bp of the 3′ end of the YMR224C ORF from S. cerevisiae [49]. A low transformation efficiency was detected, confirming the results obtained in S. cerevisiae following the nonhomologous integration of heterologous transforming DNA [50]. This could be attributed to a tolerance to DNA mismatches, a tendency to repair the DNA damage throughout the nonhomologous end–joining (NHEJ) pathway or the illegitimate recombination apparatus, or a lower efficiency of the short sequence recombination (SSR) system [51]. This result supports the phylogenetic proximity of B. bruxellensis to P. pastoris, which exhibits low transformation frequencies when homologous integration with ends–out vectors is carried out [51]. As a consequence, when proceeding with the genetic manipulation of a non–Saccharomyces yeast, and with the construction of associated molecular tools, the natural inclination towards nonhomologous recombination has to be considered. The first circular vector proposed for B. bruxellensis transformation was presented by Schifferdecker et al. in 2014. It contained CIGO 1, 2, and 3 sequences to promote the autonomous replication of the plasmid [19]. Later, Ishchuck et al. (2016) inserted CEN1 and CEN2 sequences of B. bruxellensis in several vectors [51]. In this case, the transformation efficiency was lower than that obtained using the linearized plasmid P892. Although this outcome confirmed that integrating vectors have a higher stability than replicating vectors in non–Saccharomyces yeasts, the experiment suggested that the centromeric plasmids did not contain strong autonomously replicating sequences [51,52]. In her doctoral thesis, Avramova (2017) proposed other cassettes for B. bruxellensis, i.e., pMK–T–TDH1pr–kanMX and pMK–T–TDH1pr–natMX cassettes, including the B. bruxellensis TDH1 promoter (BbTDH1) and the AgTEF2 terminator (derived from Ashbya gossypii) [53]. When these elements were integrated into the genomes of AWRI1499, AWRI1608, and AWRI1626 strains, they brought about antibiotic resistance without affecting the growth rates of the recombinants in comparison to the wild types [53]. The search for useful autonomously replicating vectors recently led to the construction of a series of pMA plasmids containing the aforementioned cassettes for G418, Nat, or Hyg as selectable markers [53,54]. The pMA–TDH1pr–natMX vector was then modified to produce the fluorescent proteins GFP (green fluorescent protein) and TagBFP (blue fluorescent protein); both were flanked by the strong S. cerevisiae promoter ScFBA1p and its terminator ScPGK1. The obtained plasmids were named pMA–TDH1pr–natMX::GFP and pMA–TDH1pr–natMX::BFP. Additionally, other plasmids containing the heterologous AgTEF2 promoter instead of the homologous BbTDH1 were constructed. However, the transformation experiments carried out with all the constructs revealed low efficiency [54]. This outcome is probably associated with the heterologous elements inserted into the vectors used, in which the BbTDH1 promoter ensured an efficiency more than seven times higher than that of AgTEF2. In fact, the tailored cassette for B. bruxellensis, coupled with multiple–drug–resistant markers and fluorescent proteins, increased the transformation efficiency [54]. All the aforementioned constructed molecular cassettes for B. bruxellensis are described in Table 4.

2.3. Transformation Protocols

Over the past 30 years, molecular tools and transformation protocols have been designed and exploited mainly for S. cerevisiae species. Nevertheless, these tools and protocols can be taken as models and applied to the manipulation of non–Saccharomyces yeasts (e.g., Yarrowia lipolytica, Pichia pastoris syn. Komagataella phaffii, Hansenula polymorpha syn. Ogataea angusta, Kluyveromyces lactis, Candida albicans, and C. glabrata) in order to study or modify metabolic traits that are useful in industrial processes [55]. In Table 5, a comparison of the different methods available for the transformation of B. bruxellensis strains is presented, considering that the well–known high genetic variability that exists in the species may create limitations. Various approaches have been proposed by a few research groups: the LiAc/PEG transformation protocol [49], electroporation treatment [49,56], the spheroplast transformation procedure, and the spheroplast intraspecific fusion methodology [49,57]. Lithium acetate treatment causes a transitional opening in the cell membranes of yeasts to permit the acquisition of genetic material from the outside; this method is highly efficient in B. bruxellensis when using up to 100 µg of DNA [49]. The electroporation method is quick and simple, whereby the exogenous DNA enters through pores in the cell wall and membrane created by a high–voltage pulse. Its efficiency significantly depends on the yeast species, cell growth phase, and final density of the culture, as well as the electroporation pulse parameters [49]. This protocol was optimized in 2015 in a study by Miklenić et al. [56], in which the electroporation pulse parameters (1.8 kV and 5 ms) and the optimal osmotic stabilizer (1M sorbitol) were established. Thereafter, this technique was utilized to transform several strains with cassettes containing genes encoding for fluorescent proteins to discriminate subpopulations by flow cytometry and fluorescent microscopy [56]. While spheroplast transformation was successfully applied in S. cerevisiae using 1 M sorbitol as the osmotic stabilizer, it resulted in a procedure unsuitable for B. bruxellensis, contrary to what was observed for the electroporation approach. Indeed, this chemical has a negative effect on this yeast species, inducing a state in which cells remain viable but become nonculturable, similar to what is observed after cell exposure to sulfite [49,58]. Another transformation technique that includes spheroplast formation is recursive intraspecific fusion based on genome shuffling. Genome shuffling is a feasible method for the rapid manipulation of complex phenotypes using whole cells and organisms. This procedure can be useful for generating stable changes in the genomes of Brettanomyces strains, and its application as an effective whole–cell engineering strategy could be advantageous for the rapid improvement of industrially important microbial phenotypes [58]. This overview shows that the most efficient strategy for B. bruxellensis transformation is the electroporation protocol proposed by Miklenić et al. in 2015 [56] and Varela et al. in 2018 [54]. However, in order to improve the knowledge and efficiency of genetic manipulation methods for different B. bruxellensis strains, additional investigations are required.

3. CRISPR/Cas9 System in B. bruxellensis

Genome editing using the CRISPR/Cas9 system is a valuable instrument for yeast genome manipulation that allows researchers to study the biochemical pathways or change the phenotypic characteristics of strains using metabolic engineering [47,55]. This breakthrough technique enables the creation of site–specific mutations in targeted locations and the integration of multiple DNA constructs in a single transformation event [59,60,61,62]. The great advantage of the CRISPR/Cas9 system is the use of a single Cas9 nuclease that can modify multiple alleles/genes simultaneously [62]. From this perspective, this method appears ideal for use in species such as B. bruxellensis that present different ploidy states [63]. Although the CRISPR/Cas9 system approach has been widely studied and applied in S. cerevisiae strains, its use in other yeast species is still challenging [64,65]. Several strategies have been developed for non–Saccharomyces yeasts (Yarrowia lipolytica, Pichia pastoris syn. Komagataella phaffii, Kluyveromyces lactis, Candida albicans, and C. glabrata), but the reported efficiencies are still lower than in S. cerevisiae strains [55]. Indeed, the crucial point of the CRISPR/Cas9 system is the insertion of double–strand breaks (DSB) and the subsequent recombination strategy; in fact, nonhomologous end joining (NHEJ) is the main route for most yeasts other than S. cerevisiae, which applies the homologous recombination (HR) strategy [65]. These two phenomena occur with different efficiencies: HR achieves precise mutations or alterations in the target locus, whereas NHEJ results in genetic mutations, deletions, and translocations [66]. Regrettably, NHEJ is the preferred DNA–repair approach in B. bruxellensis, which may prevent the possibility of overcoming the translation or deletion of genes induced by CRISPR/Cas9, limiting the survival of the transformed clones [66]. An interesting method was proposed by Weninger et al. [67] in 2017, in which the NHEJ–impeded P. pastoris CBS 7435 mutant Δku70 and the CRISPR/Cas9 system were combined to perform transformation experiments, increasing the HR efficiency. This strategy allowed them to obtain a CRISPR/Cas9–mediated integration of markerless donor cassettes with an efficiency of 100%, and, even though the transformation efficacy was lower than that achieved using conventional strategies, all the transformants demonstrated correct integration [67]. Subsequently, in 2020, Varela et al. described the application of the CRISPR/Cas9 system in B. bruxellensis [66]. In that study, several experiments were performed to obtain an expression–free CRISPR/Cas9 system to promote HR–based gene deletion in combination with B. bruxellensis gene transformation cassettes (described in the work of Varela et al. in 2018 [54] and listed above) for the deletion of the SSU1 gene responsible for sulfite tolerance [68,69,70]. This method was previously investigated for pathogenic Candida species (other than C. albicans) by Grahl et al. (2017). These authors bypassed the inefficient heterologous expression of the CRISPR/Cas9 system components in these species, delivering the ribonucleoprotein particle complex (RNPs) [71]. RNPs consist of a gRNA in complex with purified Cas9 protein. This complex is assembled in vitro and can be delivered using standard electroporation or transfection techniques [49,70]. Varela et al. obtained RNPs by co–incubating the crRNA designed to target ORF and tracrRNA. The authors achieved a targeted gene deletion of the SSU1 gene in the haploid strain AWRI2804, demonstrating growth inhibition of the mutants in the presence of SO2. Furthermore, they evaluated the possibility of using the same method in polyploid strains. They transformed the diploid strain AWRI1613 in order to delete both the URA3 genes, combining the natMX cassette, containing long–flanking regions (1 kb) and RNPs. Two ΔURA3::natMX mutants were obtained; their genome analysis revealed the integration of a single copy of the cassette and the concomitant deletion of the two different alleles, one for each mutant, thus showing the impossibility of deleting both alleles in a single step. Accordingly, a second deletion was attempted by transforming one of the mutants to combine the kanMX cassette, which contained long–flanking regions (1 kb) and RNPs. The resulting ΔURA3::kanMX showed the deletion of the second copy of the URA3 gene and the insertion of a single copy of the kanMX cassette [66]. Therefore, these outcomes support the use of this method, which combines an expression–free CRISPR/Cas9 system and tailored B. bruxellensis gene transformation cassettes and is potentially useful for polyploid strains in a stepwise transformation system.

4. Conclusions

A great amount of genetic information has been obtained about certain B. bruxellensis strains using whole–genome sequencing. However, more knowledge is required in order to develop the genetic tools necessary to efficiently engineer the species [65]. Indeed, as a result of its genomic characteristics and intraspecific heterogeneity, B. bruxellensis remains a challenge to manipulate. However, recent findings confirm that the CRISPR/Cas9 system is a promising technology for yeast engineering, as demonstrated by the rapidly increasing number of publications and the availability of many web–based bioinformatic tools for the design of gRNA [66,71,72].

Author Contributions

Conceptualization, I.V. and A.D.C.; data curation, A.D.C.; writing—original draft preparation, I.V. and A.D.C.; writing—review and editing, I.V., A.D.C., R.F. and M.M.; funding acquisition, I.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Di Canito, A.; Foschino, R.C.; Vigentini, I. DOI: 10.13130/RD_UNIMI/KCYYEB, UNIMI Dataverse, V1.

Acknowledgments

The authors gratefully acknowledge the financial support provided by Piano di Supporto alla Ricerca, Transition Grant–2020, Università degli Studi di Milano, Italy.

Conflicts of Interest

The authors declare that there is no conflict of interest.

References

  1. Smith, M.T. Dekkera van der Walt (1964). In The Yeasts, a Taxonomic Study, 5th ed.; Kurtzman, C.P., Fell, J.W., Boekhout, T., Eds.; Elsevier: London, UK, 2011; Volume 1, pp. 373–378. [Google Scholar]
  2. Yamada, Y.; Matsuda, M.; Maeda, K.; Mikata, K. The Phylogenetic Relationships of Species of the Genus Dekkera VAN DER WALT Based on the Partial Sequences of 18S and 26S Ribosomal RNAs (Saccharomycetaceae). Biosci. Biotech. Biochem. 1994, 58, 1803–1808. [Google Scholar] [CrossRef] [Green Version]
  3. Agnolucci, M.; Tirelli, A.; Cocolin, L.; Toffanin, A. Brettanomyces bruxellensis yeasts: Impact on wine and winemaking. World J. Microbiol. Biotechnol. 2017, 33, 180. [Google Scholar] [CrossRef] [PubMed]
  4. Kurtzman, C.P.; Fell, J.W.; Boekhout, T.; Robert, V. Methods for Isolation, Phenotypic Characterization and Maintenance of Yeasts. In The Yeasts, a Taxonomic Study, 5th ed.; Kurtzman, C.P., Fell, J.W., Boekhout, T., Eds.; Elsevier: London, UK, 2011; Volume 1, pp. 87–110. [Google Scholar]
  5. Péter, G.; Dlauchy, D.; Tóbiás, A.; Fülöp, L.; Podgoršek, M.; Čadež, N. Brettanomyces acidodurans sp. nov., a new acetic acid producing yeast species from olive oil. Antonie van Leeuwenhoek 2017, 110, 657–664. [Google Scholar] [CrossRef]
  6. Turland, N.J.; Wiersema, J.H.; Barrie, F.R.; Greuter, W.; Hawksworth, D.L.; Herendeen, P.S.; Knapp, S.; Kusber, W.H.; Li, D.Z.; Marhold, K.; et al. International Code of Nomenclature for Algae, Fungi, and Plants (Shenzhen Code) Adopted by the Nineteenth International Botanical Congress, Shenzhen, China, 23–29 July 2017; Regnum Vegetabile; Koeltz Botanical Books: Glashütten, Germany, 2018; Volume 159. [Google Scholar]
  7. Daniel, H.M.; Lachance, M.A.; Kurtzman, C.P. On the reclassification of species assigned to Candida and other anamorphic ascomycetous yeast genera based on phylogenetic circumscription. Antonie van Leeuwenhoek 2014, 106, 67–84. [Google Scholar] [CrossRef] [PubMed]
  8. Curtin, C.D.; Pretorius, I.S. Genomic insights into the evolution of industrial yeast species Brettanomyces bruxellensis. FEMS Yeast Res. 2014, 14, 997–1005. [Google Scholar]
  9. Colomer, M.S.; Funch, B.; Forster, J. The raise of Brettanomyces yeast species for beer production. Curr. Opin. Biotechnol. 2019, 56, 30–33. [Google Scholar] [CrossRef]
  10. Verachtert, H. Lambic and gueuze brewing: Mixed cultures in action. In Proceeding of the COMETT Course on Microbial Contaminants, Helsinki, Finland, 9–10 June 1992. [Google Scholar]
  11. Gamero, A.; Ferreira, V.; Pretorius, I.S.; Querol, A. Wine, Beer and Cider: Unravelling the Aroma Profile. In Molecular Mechanisms in Yeast Carbon Metabolism; Piškur, J., Compagno, C., Eds.; Springer: Berlin/Heidelberg, Germany, 2014; pp. 261–297. [Google Scholar]
  12. Spitaels, F.; Wieme, A.D.; Janssens, M.; Aerts, M.; Daniel, H.M.; Van Landschoot, A.; De Vuyst, L.; Vandamme, P. The Microbial Diversity of Traditional Spontaneously Fermented Lambic Beer. PLoS ONE 2014, 9, e95384. [Google Scholar] [CrossRef] [PubMed]
  13. Cortés–Diéguez, S.; Rodriguez–Solana, R.; Domínguez, J.M.; Díaz, E. Impact odorants and sensory profile of young red wines from four Galician (NW of Spain) traditional cultivars. J. Inst. Brew. 2015, 121, 628–635. [Google Scholar] [CrossRef] [Green Version]
  14. Crauwels, S.; Steensels, J.; Aerts, G.; Willems, K.; Verstrepen, K.; Lievens, B. Brettanomyces bruxellensis, essential contributor in spontaneous beer fermentations providing novel opportunities for the brewing industry. Brew. Sci. 2015, 68, 110–121. [Google Scholar]
  15. Lentz, M.; Harris, C. Analysis of Growth Inhibition and Metabolism of Hydroxycinnamic Acids by Brewing and Spoilage Strains of Brettanomyces Yeast. Foods 2015, 4, 581–593. [Google Scholar] [CrossRef] [Green Version]
  16. Castro Parente, D.; Vidal, E.E.; Leite, F.C.B.; de Barros Pita, W.; de Morais, M.A. Production of sensory compounds by means of the yeast Dekkera bruxellensis in different nitrogen sources with the prospect of producing cachaça. Yeast 2015, 32, 77–87. [Google Scholar] [PubMed] [Green Version]
  17. Vigentini, I.; Romano, A.; Compagno, C.; Merico, A.; Molinari, F.; Tirelli, A.; Foschino, R.; Volonterio, G. Physiological and oenological traits of different Dekkera/Brettanomyces bruxellensis strains under wine–model conditions. FEMS Yeast Res. 2008, 8, 1087–1096. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Chatonnet, P.; Dubourdieu, D.; Boidron, J.N. The Influence of Brettanomyces/Dekkera sp. Yeasts and Lactic Acid Bacteria on the Ethylphenol Content of Red Wines. Am. J. Enol. Vitic. 1995, 46, 463–468. [Google Scholar]
  19. Schifferdecker, A.J.; Dashko, S.; Ishchuk, O.P.; Piškur, J. The wine and beer yeast Dekkera bruxellensis. Yeast 2014, 31, 323–332. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Zuehlke, J.M.; Petrova, B.; Edwards, C.G. Advances in the Control of Wine Spoilage by Zygosaccharomyces and Dekkera/Brettanomyces. Annu. Rev. Food Sci. Technol. 2013, 4, 57–78. [Google Scholar] [CrossRef]
  21. Hellborg, L.; Piskur, J. Complex nature of the genome in a wine spoilage yeast, Dekkera bruxellensis. Eukaryot. Cell 2009, 8, 1739–1749. [Google Scholar] [CrossRef] [Green Version]
  22. Vigentini, I.; De Lorenzis, G.; Picozzi, C.; Imazio, S.; Merico, A.; Galafassi, S.; Piškur, J.; Foschino, R. Intraspecific variations of Dekkera/Brettanomyces bruxellensis genome studied by capillary electrophoresis separation of the intron splice site profiles. Int. J. Food Microbiol. 2012, 157, 6–15. [Google Scholar] [CrossRef]
  23. Avramova, M.; Cibrario, A.; Peltier, E.; Coton, M.; Coton, E.; Schacherer, J.; Spano, G.; Capozzi, V.; Blaiotta, G.; Salin, F.; et al. Brettanomyces bruxellensis population survey reveals a diploid–triploid complex structured according to substrate of isolation and geographical distribution. Sci. Rep. 2018, 8, 4136. [Google Scholar] [CrossRef]
  24. Selmecki, A.M.; Maruvka, Y.E.; Richmond, P.A.; Guillet, M.; Shoresh, N.; Sorenson, A.L.; De, S.; Kishony, R.; Michor, F.; Dowell, R.; et al. Polyploidy can drive rapid adaptation in yeast. Nature 2015, 519, 349–352. [Google Scholar] [CrossRef]
  25. Smith, B.D.; Divol, B. Brettanomyces bruxellensis, a survivalist prepared for the wine apocalypse and other beverages. Food Microbiol. 2016, 59, 161–175. [Google Scholar] [CrossRef] [PubMed]
  26. Mo, W.; Wang, M.; Zhan, R.; Yu, Y.; He, Y.; Lu, H. Kluyveromyces marxianus developing ethanol tolerance during adaptive evolution with significant improvements of multiple pathways. Biotechnol. Biofuels 2019, 12, 63. [Google Scholar] [CrossRef]
  27. Steensels, J.; Daenen, L.; Malcorps, P.; Derdelinckx, G.; Verachtert, H.; Verstrepen, K.J. Brettanomyces yeasts—From spoilage organisms to valuable contributors to industrial fermentations. Int. J. Food Microbiol. 2015, 206, 24–38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Blomqvist, J.; Passoth, V. Dekkera bruxellensis—Spoilage yeast with biotechnological potential, and a model for yeast evolution, physiology and competitiveness. FEMS Yeast Res. 2015, 15, fov021. [Google Scholar] [CrossRef] [Green Version]
  29. de Barros Pita, W.; Teles, G.H.; Peña–Moreno, I.C.; da Silva, J.M.; Ribeiro, K.C.; de Morais, M.A., Jr. The biotechnological potential of the yeast Dekkera bruxellensis. World J. Microbiol. Biotechnol. 2019, 35, 103. [Google Scholar] [CrossRef] [PubMed]
  30. Teles, G.H.; da Silva, J.M.; Mendonça, A.A.; de Morais Junior, M.A.; de Barros Pita, W. First aspects on acetate metabolism in the yeast Dekkera bruxellensis: A few keys for improving ethanol fermentation. Yeast 2018, 35, 577–584. [Google Scholar] [CrossRef] [Green Version]
  31. Park, S.W.; Hong, Y.K.; Kim, S.W.; Hong, S.I. Ethanol production by an immobilized thermotolerant mutant of Brettanomyces custersii H1–39 from wood hydrolyzate media. Korean J. Microbiol. Biotechnol. 2000, 28, 172–179. [Google Scholar]
  32. Galafassi, S.; Merico, A.; Pizza, F.; Hellborg, L.; Molinari, F.; Piškur, J.; Compagno, C. Dekkera/Brettanomyces yeasts for ethanol production from renewable sources under oxygen–limited and low–pH conditions. J. Ind. Microbiol. Biotechnol. 2011, 38, 1079–1088. [Google Scholar] [CrossRef] [PubMed]
  33. Basílio, A.C.M.; de Araújo, P.R.L.; de Morais, J.O.F.; Silva–filho, E.A.; Morais, M.A.; Simoes, D.A. Detection and Identification of Wild Yeast Contaminants of the Industrial Fuel Ethanol Fermentation Process. Curr. Microbiol. 2008, 56, 322–326. [Google Scholar] [CrossRef]
  34. Blomqvist, J.; Eberhard, T.; Schnürer, J.; Passoth, V. Fermentation characteristics of Dekkera bruxellensis strains. Appl. Microbiol. Biotechnol. 2010, 87, 1487–1497. [Google Scholar] [CrossRef] [PubMed]
  35. Pereira, L.F.; Bassi, A.P.; Avansini, S.H.; Neto, A.G.; Brasileiro, B.T.; Ceccato–Antonini, S.R.; de Morais, M.A., Jr. The physiological characteristics of the yeast Dekkera bruxellensis in fully fermentative conditions with cell recycling and in mixed cultures with Saccharomyces cerevisiae. Antonie Van Leeuwenhoek 2012, 101, 529–539. [Google Scholar] [CrossRef] [PubMed]
  36. Piškur, J.; Ling, Z.; Marcet–Houben, M.; Ishchuk, O.P.; Aerts, A.; LaButti, K.; Copeland, A.; Lindquist, E.; Barry, K.; Compagno, C.; et al. The genome of wine yeast Dekkera bruxellensis provides a tool to explore its food–related properties. Int. J. Food Microbiol. 2012, 157, 202–209. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Curtin, C.D.; Borneman, A.R.; Chambers, P.J.; Pretorius, I.S. De–Novo Assembly and Analysis of the Heterozygous Triploid Genome of the Wine Spoilage Yeast Dekkera bruxellensis AWRI1499. PLoS ONE 2012, 7, e33840. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Woolfit, M.; Rozpędowska, E.; Piškur, J.; Wolfe, K.H. Genome Survey Sequencing of the Wine Spoilage Yeast Dekkera (Brettanomyces) bruxellensis. Eukaryot. Cell 2007, 6, 721–733. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Peynaud, E.; Domercq, S. Sur les Brettanomyces isolés de raisins et de vins. Arch. Microbiol. 1956, 24, 266–280. [Google Scholar]
  40. Fournier, T.; Gounot, J.S.; Freel, K.; Cruaud, C.; Lemainque, A.; Aury, J.M.; Wincker, P.; Schacherer, J.; Friedrich, A. High–Quality de Novo Genome Assembly of the Dekkera bruxellensis Yeast Using Nanopore MinION Sequencing. G3 2017, 7, 3243–3250. [Google Scholar] [CrossRef] [Green Version]
  41. Godoy, L.; Silva–Moreno, E.; Mardones, W.; Guzman, D.; Cubillos, F.A.; Ganga, A. Genomics Perspectives on Metabolism, Survival Strategies, and Biotechnological Applications of Brettanomyces bruxellensis LAMAP2480. J. Mol. Microbiol. Biotechnol. 2017, 27, 147–158. [Google Scholar] [CrossRef]
  42. Roach, M.J.; Borneman, A.R. New genome assemblies reveal patterns of domestication and adaptation across Brettanomyces (Dekkera) species. BMC Genom. 2020, 21, 194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Tiukova, I.A.; Pettersson, M.E.; Hoeppner, M.P.; Olsen, R.A.; Käller, M.; Nielsen, J.; Dainat, J.; Lantz, H.; Söderberg, J.; Passoth, V. Chromosomal genome assembly of the ethanol production strain CBS 11270 indicates a highly dynamic genome structure in the yeast species Brettanomyces bruxellensis. PLoS ONE 2019, 14, e0215077. [Google Scholar] [CrossRef]
  44. Schiønning, H. On Torula in English Beer Manufacture*. J. Inst. Brew. 1909, 15, 2–35. [Google Scholar] [CrossRef]
  45. Colomer, M.S.; Chailyan, A.; Fennessy, R.T.; Olsson, K.F.; Johnsen, L.; Solodovnikova, N.; Forster, J. Assessing Population Diversity of Brettanomyces Yeast Species and Identification of Strains for Brewing Applications. Front. Microbiol. 2020, 11, 637. [Google Scholar] [CrossRef]
  46. Di Canito, A.; Foschino, R.C.; Vigentini, I. Brettanomyces. In UNIMI Dataverse, version 1; Universita degli Studi di Milano: Milan, Italy, 2020. [Google Scholar] [CrossRef]
  47. Vigentini, I.; Gebbia, M.; Belotti, A.; Foschino, R.; Roth, F.P. CRISPR/Cas9 System as a Valuable Genome Editing Tool for Wine Yeasts with Application to Decrease Urea Production. Front. Microbiol. 2017, 8, 2194. [Google Scholar] [CrossRef] [PubMed]
  48. Avramova, M.; Grbin, P.; Borneman, A.; Albertin, W.; Masneuf–Pomarède, I.; Varela, C. Competition experiments between Brettanomyces bruxellensis strains reveal specific adaptation to sulfur dioxide and complex interactions at intraspecies level. FEMS Yeast Res. 2019, 19, foz010. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Miklenić, M.; Štafa, A.; Bajić, A.; Žunar, B.; Lisnić, B.; Svetec, I.K. Genetic transformation of the yeast Dekkera/Brettanomyces bruxellensis with non–homologous DNA. J. Microbiol. Biotechnol. 2013, 23, 674–680. [Google Scholar] [CrossRef] [Green Version]
  50. Schiestl, R.H.; Petes, T.D. Integration of DNA fragments by illegitimate recombination in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 1991, 88, 7585–7589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Ishchuk, O.P.; Vojvoda Zeljko, T.; Schifferdecker, A.J.; Mebrahtu Wisén, S.; Hagström, Å.K.; Rozpędowska, E.; Andersen, M.R.; Hellborg, L.; Ling, Z.; Sibirny, A.A.; et al. Novel Centromeric Loci of the Wine and Beer Yeast Dekkera bruxellensis CEN1 and CEN2. PLoS ONE 2016, 11, e0161741. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Wang, T.T.; Choi, Y.J.; Lee, B.H. Transformation Systems of non–Saccharomyces Yeasts. Crit. Rev. Biotechnol. 2001, 21, 177–218. [Google Scholar] [CrossRef]
  53. Avramova, M. Génétique de Populations et Diversité de l’Espèce Brettanomyces bruxellensis. Etude de la Tolérance aux Sulfites. Ph.D. Thesis, Université de Bordeaux, Bordeaux, France, 19 December 2017. [Google Scholar]
  54. Varela, C.; Lleixà, J.; Curtin, C.; Borneman, A. Development of a genetic transformation toolkit for Brettanomyces bruxellensis. FEMS Yeast Res. 2018, 18, foy070. [Google Scholar] [CrossRef] [PubMed]
  55. Raschmanová, H.; Weninger, A.; Glieder, A.; Kovar, K.; Vogl, T. Implementing CRISPR–Cas technologies in conventional and non–conventional yeasts: Current state and future prospects. Biotechnol. Adv. 2018, 36, 641–665. [Google Scholar] [CrossRef]
  56. Miklenić, M.; Žunar, B.; Štafa, A.; Svetec, I.K. Improved electroporation procedure for genetic transformation of Dekkera/Brettanomyces bruxellensis. FEMS Yeast Res. 2015, 15, fov096. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Wu, P.; Zhao, X.; Pan, S. Intraspecific protoplast fusion of Brettanomyces anomalus for improved production of an extracellular β–glucosidase. Biotechnol. Biotechnol. Equip. 2014, 28, 878–881. [Google Scholar] [CrossRef]
  58. Serpaggi, V.; Remize, F.; Recorbet, G.; Gaudot–Dumas, E.; Sequeira–Le Grand, A.; Alexandre, H. Characterization of the “viable but nonculturable” (VBNC) state in the wine spoilage yeast Brettanomyces. Food Microbiol. 2012, 30, 438–447. [Google Scholar] [CrossRef] [PubMed]
  59. Horwitz, A.A.; Walter, J.M.; Schubert, M.G.; Kung, S.H.; Hawkins, K.; Platt, D.M.; Hernday, A.D.; Mahatdejkul–Meadows, T.; Szeto, W.; Chandran, S.S.; et al. Efficient Multiplexed Integration of Synergistic Alleles and Metabolic Pathways in Yeasts via CRISPR–Cas. Cell Syst. 2015, 1, 88–96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Jakočiūnas, T.; Bonde, I.; Herrgård, M.; Harrison, S.J.; Kristensen, M.; Pedersen, L.E.; Jensen, M.K.; Keasling, J.D. Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae. Metab. Eng. 2015, 28, 213–222. [Google Scholar] [CrossRef]
  61. Mans, R.; van Rossum, H.M.; Wijsman, M.; Backx, A.; Kuijpers, N.G.A.; van den Broek, M.; Daran–Lapujade, P.; Pronk, J.T.; van Maris, A.J.A.; Daran, J.M.G. CRISPR/Cas9: A molecular Swiss army knife for simultaneous introduction of multiple genetic modifications in Saccharomyces cerevisiae. FEMS Yeast Res. 2015, 15, fov004. [Google Scholar] [CrossRef] [Green Version]
  62. Wang, Y.; Wei, D.; Zhu, X.; Pan, J.; Zhang, P.; Huo, L.; Zhu, X. A ‘suicide’ CRISPR–Cas9 system to promote gene deletion and restoration by electroporation in Cryptococcus neoformans. Sci. Rep. 2016, 6, 31145. [Google Scholar] [CrossRef] [Green Version]
  63. Lian, J.; Bao, Z.; Hu, S.; Zhao, H. Engineered CRISPR/Cas9 system for multiplex genome engineering of polyploid industrial yeast strains. Biotechnol. Bioeng. 2018, 115, 1630–1635. [Google Scholar] [CrossRef]
  64. Cai, P.; Gao, J.; Zhou, Y. CRISPR–mediated genome editing in non–conventional yeasts for biotechnological applications. Microb. Cell Fact. 2019, 18, 63. [Google Scholar] [CrossRef] [PubMed]
  65. Shapiro, R.S.; Chavez, A.; Collins, J.J. CRISPR–based genomic tools for the manipulation of genetically intractable microorganisms. Nat. Rev. Microbiol. 2018, 16, 333–339. [Google Scholar] [CrossRef]
  66. Varela, C.; Bartel, C.; Onetto, C.; Borneman, A. Targeted gene deletion in Brettanomyces bruxellensis with an expression–free CRISPR–Cas9 system. Appl. Microbiol. Biotechnol. 2020, 104, 7105–7115. [Google Scholar] [CrossRef]
  67. Weninger, A.; Fischer, J.E.; Raschmanová, H.; Kniely, C.; Vogl, T.; Glieder, A. Expanding the CRISPR/Cas9 toolkit for Pichia pastoris with efficient donor integration and alternative resistance markers. J. Cell. Biochem. 2018, 119, 3183–3198. [Google Scholar] [CrossRef] [Green Version]
  68. Varela, C.; Bartel, C.; Roach, M.; Borneman, A.; Curtin, C. Brettanomyces bruxellensis SSU1 Haplotypes Confer Different Levels of Sulfite Tolerance When Expressed in a Saccharomyces cerevisiae SSU1 Null Mutant. Appl. Environ. Microbiol. 2019, 85, e02429-18. [Google Scholar] [CrossRef] [Green Version]
  69. Valdetara, F.; Škalič, M.; Fracassetti, D.; Louw, M.; Compagno, C.; du Toit, M.; Foschino, R.; Petrovič, U.; Divol, B.; Vigentini, I. Transcriptomics unravels the adaptive molecular mechanisms of Brettanomyces bruxellensis under SO2 stress in wine condition. Food Microbiol. 2020, 90, 103483. [Google Scholar] [CrossRef] [PubMed]
  70. Vigentini, I.; Lucy Joseph, C.; Picozzi, C.; Foschino, R.; Bisson, L.F. Assessment of the Brettanomyces bruxellensis metabolome during sulphur dioxide exposure. FEMS Yeast Res. 2013, 13, 597–608. [Google Scholar] [CrossRef] [Green Version]
  71. Grahl, N.; Demers, E.G.; Crocker, A.W.; Hogan, D.A. Use of RNA–protein complexes for genome editing in non–albicans Candida species. mSphere 2017, 2, e00218–17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Stovicek, V.; Holkenbrink, C.; Borodina, I. CRISPR/Cas system for yeast genome engineering: Advances and applications. FEMS Yeast Res. 2017, 17, fox030. [Google Scholar] [CrossRef] [PubMed]
Table
Table 1. Physiological and metabolic features of B. bruxellensis species.
Table 1. Physiological and metabolic features of B. bruxellensis species.
Features References
Growth rate (μ, h−1)0.037–0.114[29]
Ethanol yield (g/g glucose)0.44–0.46[29]
Glycerol yield (g/g glucose)0.0–0.026[28]
Crabtree positiveyes[9,20,28]
Custers effectyes[9,22,28,29]
Presence of respiratory complex 1yes[9,20,28]
Nitrate assimilationstrain specific[9,22,28]
Ethanol tolerance14%[28]
Whole–genome sequencingyes[8,36,37]
AOX1yes[9,20,28]
Phenol metabolismstrain specific[9,28]
Enzymatic activities (VPR; CD; β–glucosidase)strain specific[19,28]
SO2 tolerancestrain specific[37]
AOX1: Alcohol oxidase I; VPR: Vinyl Phenol Reductase; CD: cinnamate decarboxylase.
Table
Table 2. Complete sequenced and deposited B. bruxellensis strain genomes and their characteristics.
Table 2. Complete sequenced and deposited B. bruxellensis strain genomes and their characteristics.
StrainBioSampleBioprojectAssemblySize (Mb)GC%CDS Ecological OriginGeographical OriginReferences
CBS 2499SAMN00750237PRJNA76499GCA_000340765.113.3640.35600 wineFrance[36]
AWRI1499SAMN02261473PRJNA78661GCA_000259595.112.6839.94861 wineAustralia[37]
CBS 2796SAMN05544770PRJNA335438GCA_001719535.111.7739.8– sparkling wineFrance[38]
UMY321SAMEA5744194PRJEB33245GCA_902155815.112.9740.04666 wineItaly[22,39]
LAMAP2480SAMN09981576PRJNA231184GCA_000688595.126.9939.9– wineChile[41]
UCD 2041SAMN12257691PRJNA554210GCA_011074885.113.1539.9– fruit wineUnited States[42]
CBS 11270SAMEA104365571PRJEB11548GCA_900496985.115.3941.64879 industrial ethanolSweden[43]
CRL–50SAMN13421994PRJNA592329GCA_012295375.117.8239.8–2nbeerDenmark[45]
Table
Table 3. Test for drug sensitivities on yeast nitrogen base (YNB) medium without amino acids supplemented with 5 g L−1 ammonium sulfate [(NH4)2SO4] or 1 g L−1 L–glutamic acid (GLU) as a nitrogen source.
Table 3. Test for drug sensitivities on yeast nitrogen base (YNB) medium without amino acids supplemented with 5 g L−1 ammonium sulfate [(NH4)2SO4] or 1 g L−1 L–glutamic acid (GLU) as a nitrogen source.
Drug Concentration (µg mL−1)Geneticin (G418)Nourseothricin (NTC)Hygromicin (Hyg)Canavanine (Can)
AWRI1499CBS2499AWRI1499CBS2499AWRI1499CBS2499AWRI1499CBS2499
(NH4)2SO4GLU(NH4)2SO4GLU(NH4)2SO4GLU(NH4)2SO4GLU(NH4)2SO4GLU(NH4)2SO4GLU(NH4)2SO4GLU(NH4)2SO4GLU
0++++++++++++++++
50±–+–––––––±–––––
100±–+–––––––±–––––
200±–+–––––––±–––––
300––±–––––––––––––
400––±–––––––––––––
500––––––––––––––––
600––––––––––––––––
(+): presence of colonies; (±): few colonies; (–): no colonies.
Table
Table 4. Available molecular cassettes for B. bruxellensis manipulation.
Table 4. Available molecular cassettes for B. bruxellensis manipulation.
VectorsDrug ResistancePromotorTerminatorInsertionReferences
pMK–T–TDH1pr–kanMXKanamycin
Geneticin		BbTDH1AgTEF2BbTDH1, AgTEF2
KanR		[53,54]
pMK–T–TDH1pr–natMXKanamycin
Nourseothricin		BbTDH1AgTEF2BbTDH1, AgTEF2
NatR		[53,54]
pMK–T–TDH1pr–hygMXKanamycin
Hygromicin		BbTDH1AgTEF2BbTDH1, AgTEF2
HygR		[53,54]
pMA–TDH1pr–natMXAmpicillin
Nourseothricin		BbTDH1AgTEF2BbTDH1, AgTEF2
NatR		[53,54]
pMA–TDH1pr–natMX::GFPAmpicillin
Nourseothricin		ScFBA1ScPGK1BbTDH1, AgTEF2
NatR
GFP		[53,54]
pMA–TDH1pr–natMX::BFPAmpicillin
Nourseothricin		ScFBA1ScPGK1BbTDH1, AgTEF2
NatR
BFP		[53,54]
Table
Table 5. Available transformation approaches for B. bruxellensis manipulation.
Table 5. Available transformation approaches for B. bruxellensis manipulation.
ProcedureMediumOD600nmGrowth Temperature (°C)Solution—Chemical CompoundsTransformation EfficiencyReferences
LiAc/PEG transformationGYP; SCM0.60–0.7528 °CM LiAc–
50% PEG		16 transformants μg−1 DNA[49]
Electroporation transformationGYP0.25–0.3528 °CM LiAc–
0.5—1 M sorbitol 		2.8 × 103
transformants μg−1 DNA		[49,56]
Spheroplast transformationGYP; SCM/28 °CZymolyase–0.5 M–1 M sorbitol plating efficiency * 75%; 7.4%[49]
Spheroplast intraspecific fusionYPD; MM1.0030 °CSnailase–PE buffer–
PEG 4000		**[57]
* Alternative method to evaluate the transformation efficiency. ** Data are not available.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Di Canito, A.; Foschino, R.; Mazzieri, M.; Vigentini, I. Molecular Tools to Exploit the Biotechnological Potential of Brettanomyces bruxellensis: A Review. Appl. Sci. 2021, 11, 7302. https://doi.org/10.3390/app11167302

AMA Style

Di Canito A, Foschino R, Mazzieri M, Vigentini I. Molecular Tools to Exploit the Biotechnological Potential of Brettanomyces bruxellensis: A Review. Applied Sciences. 2021; 11(16):7302. https://doi.org/10.3390/app11167302

Chicago/Turabian Style

Di Canito, Alessandra, Roberto Foschino, Martina Mazzieri, and Ileana Vigentini. 2021. "Molecular Tools to Exploit the Biotechnological Potential of Brettanomyces bruxellensis: A Review" Applied Sciences 11, no. 16: 7302. https://doi.org/10.3390/app11167302

APA Style

Di Canito, A., Foschino, R., Mazzieri, M., & Vigentini, I. (2021). Molecular Tools to Exploit the Biotechnological Potential of Brettanomyces bruxellensis: A Review. Applied Sciences, 11(16), 7302. https://doi.org/10.3390/app11167302

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop